Researchers developed two computational tools to decode how cells communicate in tissues. sCCIgen creates realistic virtual ...

Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

ILMN's Connected Multiomics, launched after early user input, advances precision health research and may boost the stock.

Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.

Illumina, whose EMEA head office is at Granta Park in Cambridge, has released Illumina Connected Multiomics, a powerful cloud ...

Illumina, Inc. (NASDAQ: ILMN) today announced the release of Illumina Connected Multiomics, a powerful cloud-based research ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

The study also opens the door to new kinds of treatments that do not rely solely on antibiotics. Some of the surviving bacteria are fragile in specific ways, especially in their outer membranes.

Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...

“The projects awarded pilot studies grants for 2026 address important clinical and translational science questions,” says CTSI Director Sanjay Sethi, MD, SUNY Distinguished Professor of medicine and ...